Key facts
- This page summarizes Maged Shenouda's Form 4 filing for RELMADA THERAPEUTICS, INC. (RLMD).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 16 Dec 2025, 09:30.
Maged Shenouda - 12 Dec 2025 Form 4 Insider Report for RELMADA THERAPEUTICS, INC. (RLMD)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- RLMD
- Reported as of
- 12 Dec 2025
- Net transaction value
- +$48,060
- SEC form
- 4
- Accepted by SEC
- 16 Dec 2025, 09:30:24 UTC
- Prior SEC filing
- 06 Nov 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Maged Shenouda
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Maged Shenouda filed Form 4 for RELMADA THERAPEUTICS, INC. (RLMD) on 16 Dec 2025.
Change
- Previous filing in this sequence was filed on 06 Nov 2025.
- Current net transaction value: +$48,060.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001658369
Primary reporting owner
Shenouda Maged
- Relationship
- Chief Financial Officer
- Address
- C/O RELMADA THERAPEUTICS, INC., 2222 PONCE DE LEON BLVD, 3RD FLOOR, CORAL GABLES
- Signature
- /s/ Maged Shenouda
- Signature date
- 16 Dec 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RLMD
transaction
Common Stock
Purchase
- Transaction value
- $48,060
- Shares
- +11,665
- Change %
- +1.5%
- Price
- $4.12
- Shares after
- 800,000
- Date
- 15 Dec 2025
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
RLMD
transaction
Derivative
Stock Appreciation Rights
Award
- Transaction value
- $0
- Shares
- +828,000
- Change %
- Price
- $0.000000
- Shares after
- 828,000
- Date
- 12 Dec 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 828,000
- Exercise price
- $4.06
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The stock appreciation rights vest in 16 equal quarterly installments commencing on March 12, 2026.